Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Condition(s):Prostatic NeoplasmsLast Updated:May 27, 2020Withdrawn
Hide Studies Not Open or Pending
Condition(s):Prostatic NeoplasmsLast Updated:May 27, 2020Withdrawn
Condition(s):Gallbladder NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Uterine Cervical NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Extremities NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Hilus Pulmonary NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Pancreatic CancerLast Updated:January 22, 2021Completed
Condition(s):Urinary Bladder NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Lymph Node MetastasesLast Updated:September 5, 2021Completed
Condition(s):Head and Neck NeoplasmsLast Updated:September 5, 2021Completed
Condition(s):Colorectal Metastases to the LungLast Updated:January 8, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.